New blood test to detect skin cancer at an early stage

Melanoma could be detected by a blood test. A scientific evolution that could help fight against this cancer that affects millions of Americans.

A blood test would have been put in place and would be effective in helping doctors detect melanoma, an aggressive skin cancer, before it spreads in the body, according to a study published in the medical journal Oncotarget.

Scientists at Edith Cowan University in Australia conducted a trial with 105 patients with primary melanoma and 104 people in good health. The blood test put in place by the scientists allowed to detect a melanoma at an early stage in 79% of the cases. It is able to identify autoantibodies produced by a patient in response to the cancer.

“We examined a total of 1,627 different types of antibodies to identify a combination of 10 antibodies that are the best indicators of the presence of melanoma in affected patients compared to healthy volunteers,” continued the researcher.

According to the World Health Organization, one in three cancer cases is skin cancer.

“Patients whose melanoma is detected at an early stage have a five-year survival rate between 90 and 99%,” said study director Pauline Zaenker. Otherwise, this rate drops to less than 50%.

“That’s why this blood test is so promising as a potential detection tool because it can detect melanoma in the very early phase, when it is still treatable,” she added.

If the results of this study are encouraging, researchers must implement these clinical trials before this blood test is offered to health professionals for screening for melanoma.

Shakes Gilles

Editor of The Talking Democrat. He enjoys bike riding, kayaking and playing soccer. On a slow weekend, you'll find him with a book by the lake.